Duk-woo Park, Md

This study compares a new stomach acid reducer (tegoprazan) with a standard one (rabeprazole) in about 3,320 heart patients who take blood thinners and are at high risk for stomach bleeding or ulcers. The goal is to see if the new drug works just as well at preventing serious sto…

This study compares two advanced heart procedures—stent placement (PCI) and bypass surgery (CABG)—in 1,500 people with diabetes and three blocked arteries. The goal is to see which approach better prevents death, heart attacks, or strokes. Participants are randomly assigned to on…

This study tests whether a daily pill called enavogliflozin (a type of SGLT2 inhibitor) can reduce the risk of major heart problems or worsening heart failure in people who have already had a valve replacement (TAVR) for severe aortic stenosis and still have heart failure with pr…

This study is a large registry that will follow 10,000 people who have had a TAVR procedure to replace a faulty heart valve. The goal is to see how well the procedure works over the long term in everyday medical practice. Researchers will track deaths, heart attacks, and other he…